ArticleJournal of pharmaceutical analysis2024

Increasing the tumour targeting of antitumour drugs through anlotinib-mediated modulation of the extracellular matrix and the RhoA/ROCK signalling pathway.

Xuedan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.